Beatriz A. Anjos G. Veiga
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Beatriz A. Anjos G. Veiga has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Carina França
Movement Disorders Center, Department of Neurology, Hospital das Clínicas, University of São Paulo, São Paulo 05403-010, Brazil
1 shared publication - Carlos Eduardo Mantese
Hospital Mãe de Deus, Brazil
1 shared publication - Carlos Roberto Mello Rieder
Universidade Federal de Ciências da Saúde de Porto Alegre, Departamento de Neurologia, Porto Alegre RS, Brazil
1 shared publication Carolina Candeias da Silva
1 shared publication- Clecio Godeiro-Junior
Division of Neurology, Hospital Universitário Onofre Lopes Universidade Federal do Rio Grande do Norte Natal Brazil
1 shared publication - Danilo Donizete de Faria
Department of Neurology and Neurosurgery, Universidade Federal de São Paulo, São Paulo, Brazil
1 shared publication
Latest Publications
- 28 December 2024
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 249
Are impulsive compulsive behaviors associated with levodopa-induced dyskinesia? A Brazilian cross-sectional study
- 28 December 2024
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 249
Are impulsive compulsive behaviors associated with levodopa-induced dyskinesia? A Brazilian cross-sectional study
- Open Access
- 1 July 2021
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 79 (7) , 630-646
Use of non-invasive stimulation in movement disorders: a critical review
Background: Noninvasive stimulation has been widely used in the past 30 years to study and treat a large number of neurological diseases, including movement disorders. Objective: In this critical review, we illustrate the rationale for use of these techniques in movement disorders and summarize the best medical evidence based on the main clinical trials performed to date. Methods: A nationally representative group of experts performed a comprehensive review of the literature in order to analyze the key clinical decision-making factors driving transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) in movement disorders. Classes of evidence and recommendations were described for each disease. Results: Despite unavoidable heterogeneities and low effect size, TMS is likely to be effective for treating motor symptoms and depression in Parkinson’s disease (PD). The efficacy in other movement disorders is unclear. TMS is possibly effective for focal hand dystonia, essential tremor and cerebellar ataxia. Additionally, it is likely to be ineffective in reducing tics in Tourette syndrome. Lastly, tDCS is likely to be effective in improving gait in PD. Conclusions: There is encouraging evidence for the use of noninvasive stimulation on a subset of symptoms in selected movement disorders, although the means to optimize protocols for improving positive outcomes in routine clinical practice remain undetermined. Similarly, the best stimulation paradigms and responder profile need to be investigated in large clinical trials with established therapeutic and assessment paradigms that could also allow genuine long-term benefits to be determined.
- 1 July 2021
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 79 (7) , 630-646
Open AccessUse of non-invasive stimulation in movement disorders: a critical review
Background: Noninvasive stimulation has been widely used in the past 30 years to study and treat a large number of neurological diseases, including movement disorders. Objective: In this critical review, we illustrate the rationale for use of these techniques in movement disorders and summarize the best medical evidence based on the main clinical trials performed to date. Methods: A nationally representative group of experts performed a comprehensive review of the literature in order to analyze the key clinical decision-making factors driving transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) in movement disorders. Classes of evidence and recommendations were described for each disease. Results: Despite unavoidable heterogeneities and low effect size, TMS is likely to be effective for treating motor symptoms and depression in Parkinson’s disease (PD). The efficacy in other movement disorders is unclear. TMS is possibly effective for focal hand dystonia, essential tremor and cerebellar ataxia. Additionally, it is likely to be ineffective in reducing tics in Tourette syndrome. Lastly, tDCS is likely to be effective in improving gait in PD. Conclusions: There is encouraging evidence for the use of noninvasive stimulation on a subset of symptoms in selected movement disorders, although the means to optimize protocols for improving positive outcomes in routine clinical practice remain undetermined. Similarly, the best stimulation paradigms and responder profile need to be investigated in large clinical trials with established therapeutic and assessment paradigms that could also allow genuine long-term benefits to be determined.